Federated Hermes Inc. Has $30.86 Million Stock Holdings in Lam Research Corporation $LRCX

Federated Hermes Inc. trimmed its position in Lam Research Corporation (NASDAQ:LRCX) by 46.3% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 317,034 shares of the semiconductor company’s stock after selling 273,816 shares during the period. Federated Hermes Inc.’s holdings in Lam Research were worth $30,860,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Vanguard Group Inc. raised its position in shares of Lam Research by 1.1% during the second quarter. Vanguard Group Inc. now owns 130,609,265 shares of the semiconductor company’s stock worth $12,713,506,000 after purchasing an additional 1,457,163 shares during the period. JPMorgan Chase & Co. raised its holdings in Lam Research by 14.4% during the second quarter. JPMorgan Chase & Co. now owns 40,622,437 shares of the semiconductor company’s stock worth $3,954,188,000 after buying an additional 5,102,589 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of Lam Research by 3.5% in the second quarter. Geode Capital Management LLC now owns 33,802,736 shares of the semiconductor company’s stock valued at $3,280,484,000 after buying an additional 1,135,405 shares in the last quarter. Norges Bank acquired a new position in shares of Lam Research during the second quarter valued at about $1,894,585,000. Finally, Invesco Ltd. increased its position in shares of Lam Research by 3.4% during the second quarter. Invesco Ltd. now owns 17,919,290 shares of the semiconductor company’s stock worth $1,744,264,000 after acquiring an additional 588,519 shares in the last quarter. Institutional investors own 84.61% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the stock. Cowen reaffirmed a “buy” rating on shares of Lam Research in a research report on Thursday, October 23rd. Zacks Research cut Lam Research from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 24th. Berenberg Bank increased their price target on Lam Research from $122.00 to $165.00 and gave the company a “buy” rating in a research report on Thursday, October 23rd. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $170.00 price objective on shares of Lam Research in a report on Thursday, October 23rd. Finally, Hsbc Global Res upgraded shares of Lam Research to a “hold” rating in a research note on Tuesday, September 30th. Twenty-six analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. According to data from MarketBeat.com, Lam Research presently has a consensus rating of “Moderate Buy” and a consensus price target of $152.87.

Insider Buying and Selling

In other news, CFO Douglas R. Bettinger sold 40,080 shares of the company’s stock in a transaction dated Friday, November 14th. The stock was sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the sale, the chief financial officer directly owned 987,237 shares in the company, valued at $148,677,892.20. This represents a 3.90% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, SVP Vahid Vahedi sold 52,190 shares of the stock in a transaction dated Monday, October 13th. The stock was sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the completion of the sale, the senior vice president directly owned 251,047 shares in the company, valued at approximately $34,870,428.30. The trade was a 17.21% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 102,608 shares of company stock worth $14,916,496 over the last quarter. 0.31% of the stock is owned by corporate insiders.

Lam Research Stock Performance

Shares of LRCX stock opened at $165.81 on Wednesday. The firm’s 50 day moving average is $151.29 and its 200 day moving average is $118.75. The stock has a market capitalization of $208.26 billion, a P/E ratio of 36.52, a PEG ratio of 1.67 and a beta of 1.77. Lam Research Corporation has a 12 month low of $56.32 and a 12 month high of $167.15. The company has a current ratio of 2.21, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37.

Lam Research (NASDAQ:LRCX) last issued its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.22 by $0.04. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The business had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.23 billion. During the same quarter in the previous year, the firm posted $0.86 EPS. The business’s revenue for the quarter was up 27.7% compared to the same quarter last year. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. On average, sell-side analysts anticipate that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 7th. Shareholders of record on Wednesday, December 3rd will be paid a $0.26 dividend. The ex-dividend date is Wednesday, December 3rd. This represents a $1.04 annualized dividend and a yield of 0.6%. Lam Research’s dividend payout ratio (DPR) is currently 22.91%.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.